CTOs on the Move

Fidelis Care

www.fideliscare.org

 
Fidelis Care is the New York State Catholic Health Plan, providing quality, affordable, New York State-sponsored health insurance coverage for people of all ages and at all stages of life. From its origin in 1993 as the Catholic Health Services Plan of Brooklyn and Queens, Inc., Fidelis Care has grown -- both in the scope of its mission and the services it provides. Today, through a Statewide network of more than 67,000 providers, we support more than one million children and adults, making Fidelis Care one of the largest government programs-based health insurance plans in New York State. Fidelis Care ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details

Similar Companies

L-Nutra

L-Nutra is a nutri-technology company dedicated to helping people increase their healthspan (healthy years of their lives) through fasting and nutrition with the launch of our first product The Fasting Mimicking Diet.

Cyanotech Corporation

Cyanotech Corporation is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Kailua Kona, HI. To find more information about Cyanotech Corporation, please visit www.cyanotech.com

fuzion sports club

fuzion sports club is a Canton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

OncoGenex

OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.

Cryopen

Cryopen is a Covington, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.